https://www.firstwordhealthtech.com/story/5570485
Remedee Labs announced Thursday that the FDA granted a breakthrough therapy device designation to its endorphin stimulator for patients with fibromyalgia. CEO David Crouzier called the achievement a "major step, one that recognises [the...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.